Source:http://linkedlifedata.com/resource/pubmed/id/19051197
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-12-29
|
pubmed:abstractText |
A series of 2-substituted xanthone derivatives 8-20 containing selected allyl, cinnamyl, morpholine, and imidazole moieties were synthesized and tested for their antifungal and antibacterial in-vitro properties. Of the newly synthesized derivatives, ten revealed antifungal activity especially against Trichophyton mentagrophytes (the biggest inhibition zones ranged 35 mm for 11 and 13). 2-(3-(Allylamino)propoxy)-9H-xanthen-9-one hydrochloride 9 inhibited growth of all of the examined fungal species. Significant efficacy against evaluated yeasts and dermatophytes was also observed for 6-chloro-2-methyl-9H-xanthen-9-one derivatives 11-13 containing encyclic amine moieties. Additionally, compounds 9, 11, and 12 hindered development of bacteria species but in a lesser degree. They were efficacious against Staphylococcus aureus, Escherichia coli, and Enterococcus faecalis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1521-4184
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
342
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
9-18
|
pubmed:dateRevised |
2009-5-20
|
pubmed:meshHeading |
pubmed-meshheading:19051197-Anti-Bacterial Agents,
pubmed-meshheading:19051197-Antifungal Agents,
pubmed-meshheading:19051197-Arthrodermataceae,
pubmed-meshheading:19051197-Enterococcus faecalis,
pubmed-meshheading:19051197-Escherichia coli,
pubmed-meshheading:19051197-Staphylococcus aureus,
pubmed-meshheading:19051197-Structure-Activity Relationship,
pubmed-meshheading:19051197-Xanthones,
pubmed-meshheading:19051197-Yeasts
|
pubmed:year |
2009
|
pubmed:articleTitle |
Antifungal and antibacterial activity of the newly synthesized 2-xanthone derivatives.
|
pubmed:affiliation |
Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College, Cracow, Poland. hen.mar@interia.pl
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|